Nicole R. Hadas, SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA), sold 13,034 shares at $0.88 ($11K) on 2023-03-01, disclosed to the SEC on 2023-03-03.
Seasonal sale ($11k) by SVP, Chief Legal Officer — this insider has traded AKBA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.88 | 1,088 | $957 | 8.3% |
| 2 | $0.88 | 5,333 | $5K | 40.9% |
| 3 | $0.88 | 6,613 | $6K | 50.7% |
| Total | $0.88 avg | 13,034 | $11K | 100% |
| Filing → |
| AKBA | SELL | 2024-02-29 | $11K | — | Filing → |
| AKBA | SELL | 2023-05-25 | $154K | — | Filing → |
| AKBA | SELL | 2023-03-01 | $5K | — | Filing → |